Publisher Correction: Design and efficient synthesis of pyrazoline and isoxazole bridged indole C-glycoside hybrids as potential anticancer agents (Scientific Reports, (2020), 10, 1, (6660), 10.1038/s41598-020-63377-x)

Priti Kumari; Vishnu S. Mishra; Chintam Narayana; Ashish Khanna; Anindita Chakrabarty; Ram Sagar

ArticleOPEN ACCESS

Publisher Correction: Design and efficient synthesis of pyrazoline and isoxazole bridged indole C-glycoside hybrids as potential anticancer agents (Scientific Reports, (2020), 10, 1, (6660), 10.1038/s41598-020-63377-x)

Scientific Reports

DOI: 10.1038/s41598-020-67068-5

3Citations

26Readers

Abstract

This Article contains an incorrect version of Scheme 1 and Scheme 2. The correct version of Scheme 1 and Scheme 2 appears below.

Cite

CITATION STYLE

APA

Kumari, P., Mishra, V. S., Narayana, C., Khanna, A., Chakrabarty, A., & Sagar, R. (2020, December 1). Publisher Correction: Design and efficient synthesis of pyrazoline and isoxazole bridged indole C-glycoside hybrids as potential anticancer agents (Scientific Reports, (2020), 10, 1, (6660), 10.1038/s41598-020-63377-x). Scientific Reports. Nature Research. https://doi.org/10.1038/s41598-020-67068-5

Publisher Correction: Design and efficient synthesis of pyrazoline and isoxazole bridged indole C-glycoside hybrids as potential anticancer agents (Scientific Reports, (2020), 10, 1, (6660), 10.1038/s41598-020-63377-x)

Abstract

Cite

Register to see more suggestions